Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEVACIZUMAB-AWWB: 4,137 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
4,137
Total FAERS Reports
89 (2.2%)
Deaths Reported
307
Hospitalizations
4,137
As Primary/Secondary Suspect
43
Life-Threatening
45
Disabilities
Prescription
Status

FDA Application: 761028 ·

First Report: 20130814 · Latest Report: 20250916

What Are the Most Common BEVACIZUMAB-AWWB Side Effects?

#1 Most Reported
Off label use
441 reports (10.7%)
#2 Most Reported
Product storage error
437 reports (10.6%)
#3 Most Reported
Circumstance or information capable of leading to medication error
346 reports (8.4%)

All BEVACIZUMAB-AWWB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Off label use 441 10.7% 15 58
Product storage error 437 10.6% 0 0
Circumstance or information capable of leading to medication error 346 8.4% 0 0
Hypertension 187 4.5% 4 13
Blood pressure increased 163 3.9% 0 3
Disease progression 160 3.9% 6 8
Product dose omission issue 158 3.8% 0 0
Adverse event 143 3.5% 0 1
Platelet count decreased 118 2.9% 1 3
Fatigue 104 2.5% 4 19
Intercepted product administration error 97 2.3% 0 0
Nausea 91 2.2% 3 11
Accidental exposure to product 89 2.2% 0 0
Malaise 83 2.0% 1 5
Diarrhoea 78 1.9% 3 12
Ill-defined disorder 71 1.7% 0 2
Unevaluable event 71 1.7% 2 14
Vomiting 65 1.6% 4 12
Abdominal pain 63 1.5% 1 9
Asthenia 63 1.5% 1 19

Who Reports BEVACIZUMAB-AWWB Side Effects? Age & Gender Data

Gender: 61.4% female, 38.6% male. Average age: 62.9 years. Most reports from: US. View detailed demographics →

Is BEVACIZUMAB-AWWB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 1 0 1
2017 2 0 1
2018 3 0 1
2019 18 0 2
2020 184 6 32
2021 428 15 43
2022 538 15 46
2023 565 10 42
2024 387 7 41
2025 253 3 21

View full timeline →

What Is BEVACIZUMAB-AWWB Used For?

IndicationReports
Product used for unknown indication 2,584
Ovarian cancer 242
Colon cancer 179
Hepatocellular carcinoma 108
Colorectal cancer 96
Glioblastoma 78
Rectal cancer 77
Age-related macular degeneration 56
Off label use 54
Adenocarcinoma of colon 50

BEVACIZUMAB-AWWB vs Alternatives: Which Is Safer?

BEVACIZUMAB-AWWB vs BEVACIZUMAB-BVZR BEVACIZUMAB-AWWB vs BEVACIZUMAB-MALY BEVACIZUMAB-AWWB vs BEXAROTENE BEVACIZUMAB-AWWB vs BEZAFIBRATE BEVACIZUMAB-AWWB vs BEZLOTOXUMAB BEVACIZUMAB-AWWB vs BGB-11417 BEVACIZUMAB-AWWB vs BICALUTAMIDE BEVACIZUMAB-AWWB vs BICTEGRAVIR BEVACIZUMAB-AWWB vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BEVACIZUMAB-AWWB vs BIFIDOBACTERIUM LONGUM

Official FDA Label for BEVACIZUMAB-AWWB

Official prescribing information from the FDA-approved drug label.